MX2013013859A - Nuevos derivados de imidazol utiles para el tratamiento de artritis. - Google Patents
Nuevos derivados de imidazol utiles para el tratamiento de artritis.Info
- Publication number
- MX2013013859A MX2013013859A MX2013013859A MX2013013859A MX2013013859A MX 2013013859 A MX2013013859 A MX 2013013859A MX 2013013859 A MX2013013859 A MX 2013013859A MX 2013013859 A MX2013013859 A MX 2013013859A MX 2013013859 A MX2013013859 A MX 2013013859A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- termination end
- beam sections
- arthritis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente invención se refiere a compuestos de la fórmula siguiente: donde A, X y R1-R6 son como se describen en la presente, una sal farmacéutica del mismo, y una composición farmacéutica que contiene este compuesto; métodos para tratar dolor asociado con osteoartritis usando uno de los compuestos o una sal del mismo farmacéuticamente aceptable, y procesos para preparar los compuestos (Ver Formula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161490222P | 2011-05-26 | 2011-05-26 | |
PCT/US2012/037200 WO2012161965A1 (en) | 2011-05-26 | 2012-05-10 | Novel imidazole derivatives useful for the treatment of arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013013859A true MX2013013859A (es) | 2014-05-28 |
Family
ID=46148987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013013859A MX2013013859A (es) | 2011-05-26 | 2012-05-10 | Nuevos derivados de imidazol utiles para el tratamiento de artritis. |
Country Status (22)
Country | Link |
---|---|
US (1) | US8648200B2 (es) |
EP (1) | EP2714679A1 (es) |
JP (1) | JP2014518886A (es) |
KR (1) | KR20130143138A (es) |
CN (1) | CN103562200A (es) |
AR (1) | AR086254A1 (es) |
AU (1) | AU2012259234A1 (es) |
BR (1) | BR112013029692A2 (es) |
CA (1) | CA2836240A1 (es) |
CO (1) | CO6811858A2 (es) |
CR (1) | CR20130534A (es) |
DO (1) | DOP2013000276A (es) |
EA (1) | EA201391568A1 (es) |
EC (1) | ECSP13013047A (es) |
IL (1) | IL229318A0 (es) |
MA (1) | MA35128B1 (es) |
MX (1) | MX2013013859A (es) |
SG (1) | SG195020A1 (es) |
TN (1) | TN2013000434A1 (es) |
TW (1) | TW201311658A (es) |
WO (1) | WO2012161965A1 (es) |
ZA (1) | ZA201308609B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8871947B2 (en) | 2013-02-04 | 2014-10-28 | KingChem LLC | Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester |
CN103467379A (zh) * | 2013-08-23 | 2013-12-25 | 江苏恒安化工有限公司 | 3-三氟甲基-1-甲基吡唑-4-甲酸的制备方法 |
CN103483250B (zh) * | 2013-10-08 | 2015-07-22 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
CN103601675B (zh) * | 2013-10-08 | 2015-10-28 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
CN104379551B (zh) | 2013-12-09 | 2017-03-08 | 金凯有限责任公司 | 3‑二氟甲基‑1‑甲基‑1h‑吡唑‑4‑羧酸烷基酯及其类似物的制备方法 |
TWI651310B (zh) * | 2014-02-20 | 2019-02-21 | 日商日本煙草產業股份有限公司 | 三化合物及其醫藥用途 |
JP6566444B2 (ja) | 2014-03-19 | 2019-08-28 | カーザ グローバル エルエルシーCurza Global, Llc | 2−(アシルアミノ)イミダゾールを含む組成物および方法 |
RU2681537C2 (ru) | 2014-04-14 | 2019-03-07 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение |
BR112018001809A2 (pt) * | 2015-08-17 | 2018-09-18 | Japan Tobacco, Inc. | composto de hidroxitriazina e uso médico do mesmo |
US11447503B2 (en) | 2019-06-14 | 2022-09-20 | Janssen Pharmaceutica Nv | Pyridine carbamates and their use as GLUN2B receptor modulators |
JP2020512981A (ja) | 2017-03-31 | 2020-04-30 | カーザ グローバル,リミティド ライアビリティ カンパニー | 置換2−アミノイミダゾールを含む組成物と方法 |
CN109293567A (zh) * | 2018-11-23 | 2019-02-01 | 上海睿腾医药科技有限公司 | 一种5-溴-2-甲基烟酸乙酯的合成方法 |
CA3142513A1 (en) | 2019-06-25 | 2020-12-30 | Gilead Sciences, Inc. | Flt3l-fc fusion proteins and methods of use |
AU2020365113A1 (en) | 2019-10-18 | 2022-04-07 | Forty Seven, Inc. | Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia |
MX2022005123A (es) | 2019-10-31 | 2022-05-30 | Forty Seven Inc | Tratamiento basado en anti-cd47 y anti-cd20 para cancer hematologico. |
TWI778443B (zh) | 2019-11-12 | 2022-09-21 | 美商基利科學股份有限公司 | Mcl1抑制劑 |
CN110845426A (zh) * | 2019-11-29 | 2020-02-28 | 都创(上海)医药科技有限公司 | 一种2-氯-5-氰基嘧啶化合物制备方法 |
CA3165735A1 (en) | 2019-12-24 | 2021-07-01 | Carna Biosciences, Inc. | Diacylglycerol kinase modulating compounds |
BR112022014623A2 (pt) | 2020-02-14 | 2022-09-13 | Jounce Therapeutics Inc | Anticorpos e proteínas de fusão que se ligam a ccr8 e usos dos mesmos |
US20230039553A1 (en) | 2020-05-01 | 2023-02-09 | Gilead Sciences, Inc. | Cd73 compounds |
TW202302145A (zh) | 2021-04-14 | 2023-01-16 | 美商基利科學股份有限公司 | CD47/SIRPα結合及NEDD8活化酶E1調節次單元之共抑制以用於治療癌症 |
TW202313094A (zh) | 2021-05-18 | 2023-04-01 | 美商基利科學股份有限公司 | 使用FLT3L—Fc融合蛋白之方法 |
US11926628B2 (en) | 2021-06-23 | 2024-03-12 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
US11976072B2 (en) | 2021-06-23 | 2024-05-07 | Gilead Sciences, Inc. | Diacylglycerol kinase modulating compounds |
CA3220923A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
AU2022298639A1 (en) | 2021-06-23 | 2023-12-07 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2023076983A1 (en) | 2021-10-28 | 2023-05-04 | Gilead Sciences, Inc. | Pyridizin-3(2h)-one derivatives |
AU2022376954A1 (en) | 2021-10-29 | 2024-05-02 | Gilead Sciences, Inc. | Cd73 compounds |
WO2023122581A2 (en) | 2021-12-22 | 2023-06-29 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
US20230242508A1 (en) | 2021-12-22 | 2023-08-03 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
TW202340168A (zh) | 2022-01-28 | 2023-10-16 | 美商基利科學股份有限公司 | Parp7抑制劑 |
TW202346277A (zh) | 2022-03-17 | 2023-12-01 | 美商基利科學股份有限公司 | Ikaros鋅指家族降解劑及其用途 |
US20230355796A1 (en) | 2022-03-24 | 2023-11-09 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
TW202345901A (zh) | 2022-04-05 | 2023-12-01 | 美商基利科學股份有限公司 | 用於治療結腸直腸癌之組合療法 |
TW202400138A (zh) | 2022-04-21 | 2024-01-01 | 美商基利科學股份有限公司 | Kras g12d調節化合物 |
US20240116928A1 (en) | 2022-07-01 | 2024-04-11 | Gilead Sciences, Inc. | Cd73 compounds |
US20240091351A1 (en) | 2022-09-21 | 2024-03-21 | Gilead Sciences, Inc. | FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7439360B2 (en) * | 2004-10-15 | 2008-10-21 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US8084466B2 (en) * | 2007-12-18 | 2011-12-27 | Janssen Pharmaceutica Nv | Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor |
WO2009103778A1 (en) | 2008-02-19 | 2009-08-27 | Novasaid Ab | Compounds and methods |
UY32470A (es) | 2009-03-05 | 2010-10-29 | Boehringer Ingelheim Int | Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones |
WO2010127152A2 (en) | 2009-04-29 | 2010-11-04 | Irm Llc | Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors |
JP5579862B2 (ja) * | 2009-10-23 | 2014-08-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ミクロソームプロスタグランジンe2シンターゼ−1のインヒビター |
AR084174A1 (es) * | 2010-12-21 | 2013-04-24 | Lilly Co Eli | Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica |
-
2012
- 2012-05-03 AR ARP120101556A patent/AR086254A1/es not_active Application Discontinuation
- 2012-05-04 TW TW101116086A patent/TW201311658A/zh unknown
- 2012-05-10 US US13/468,122 patent/US8648200B2/en not_active Expired - Fee Related
- 2012-05-10 BR BR112013029692A patent/BR112013029692A2/pt not_active IP Right Cessation
- 2012-05-10 MX MX2013013859A patent/MX2013013859A/es unknown
- 2012-05-10 WO PCT/US2012/037200 patent/WO2012161965A1/en active Application Filing
- 2012-05-10 EA EA201391568A patent/EA201391568A1/ru unknown
- 2012-05-10 JP JP2014512861A patent/JP2014518886A/ja active Pending
- 2012-05-10 SG SG2013085154A patent/SG195020A1/en unknown
- 2012-05-10 EP EP12723323.7A patent/EP2714679A1/en not_active Withdrawn
- 2012-05-10 CN CN201280025230.2A patent/CN103562200A/zh active Pending
- 2012-05-10 KR KR1020137030893A patent/KR20130143138A/ko not_active Application Discontinuation
- 2012-05-10 CA CA2836240A patent/CA2836240A1/en not_active Abandoned
- 2012-05-10 AU AU2012259234A patent/AU2012259234A1/en not_active Abandoned
-
2013
- 2013-10-18 CR CR20130534A patent/CR20130534A/es unknown
- 2013-10-24 TN TNP2013000434A patent/TN2013000434A1/fr unknown
- 2013-11-07 IL IL229318A patent/IL229318A0/en unknown
- 2013-11-15 MA MA36452A patent/MA35128B1/fr unknown
- 2013-11-15 ZA ZA2013/08609A patent/ZA201308609B/en unknown
- 2013-11-22 CO CO13275568A patent/CO6811858A2/es not_active Application Discontinuation
- 2013-11-22 DO DO2013000276A patent/DOP2013000276A/es unknown
- 2013-11-25 EC ECSP13013047 patent/ECSP13013047A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO6811858A2 (es) | 2013-12-16 |
AU2012259234A1 (en) | 2013-11-14 |
IL229318A0 (en) | 2014-01-30 |
JP2014518886A (ja) | 2014-08-07 |
SG195020A1 (en) | 2013-12-30 |
CR20130534A (es) | 2014-03-12 |
AR086254A1 (es) | 2013-11-27 |
US8648200B2 (en) | 2014-02-11 |
MA35128B1 (fr) | 2014-05-02 |
ECSP13013047A (es) | 2014-01-31 |
ZA201308609B (en) | 2015-05-27 |
DOP2013000276A (es) | 2014-03-31 |
KR20130143138A (ko) | 2013-12-30 |
WO2012161965A1 (en) | 2012-11-29 |
BR112013029692A2 (pt) | 2017-01-17 |
TN2013000434A1 (en) | 2015-03-30 |
EP2714679A1 (en) | 2014-04-09 |
US20120302608A1 (en) | 2012-11-29 |
EA201391568A1 (ru) | 2014-04-30 |
TW201311658A (zh) | 2013-03-16 |
CN103562200A (zh) | 2014-02-05 |
CA2836240A1 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013013859A (es) | Nuevos derivados de imidazol utiles para el tratamiento de artritis. | |
MX2021000781A (es) | Profarmacos de amidas de piridona utiles como moduladores de canales de sodio. | |
MY176814A (en) | Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis | |
UA109220C2 (uk) | Похідні (4-фенілімідазол-2-іл)етиламіну як модулятори натрієвих каналів | |
PH12017502201A1 (en) | Substituted pyridines and method of use | |
CY1118678T1 (el) | Παραγωγα καρβοξαμιδιου χλωρο-πυραζινης χρησιμα για την θεραπευτικη αντιμετωπιση ασθενειων που ευνοουνται απο την ανεπαρκη ενυδατωση του βλεννογονου | |
MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
MX2015014298A (es) | Compuestos de dihidropirido pirimidina como inhibidores de autotaxina. | |
NZ710111A (en) | Quinoline and quinoxaline amides as modulators of sodium channels | |
MX341565B (es) | 3-amino-piridinas como agonistas de receptor de acido biliar acoplado a proteina g1 (gpbar1). | |
UA110983C2 (uk) | Похідна 1,2,3,4-тетрагідрохіноліну, придатна для лікування діабету | |
MX2021010046A (es) | Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas. | |
WO2014153203A3 (en) | Alkyl-amine harmine derivatives for promoting bone growth | |
MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
MY176246A (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
NZ711343A (en) | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation | |
MX2014010910A (es) | Sales novedosas de trimebutina basadas en sulfonato. | |
MX2018008966A (es) | Procesos mejorados para la preparacion de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo. | |
MD20160111A2 (ro) | Derivaţi diheterociclici legaţi de cicloalchil | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
PT2454266E (pt) | Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)- 7,12,25-trioxa-19,21,24-triaza-tetraciclo- [18.3.1.1(2,5).1(14)18)]hexacosa- 1(24),2,4,9,14,16,18(26),20,22-nonaeno | |
UA116994C2 (uk) | Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять | |
MX2014014816A (es) | Composicion farmaceutica para tratar inflamacion y dolor. | |
MX2015000064A (es) | Compuestos de acrilamida como ligandos receptores de histamina h3. | |
WO2012150607A3 (en) | Oral liquid composition comprising divalproex sodium and process for preparing thereof |